vs

Side-by-side financial comparison of ANAPTYSBIO, INC (ANAB) and Xperi Inc. (XPER). Click either name above to swap in a different company.

Xperi Inc. is the larger business by last-quarter revenue ($116.5M vs $108.2M, roughly 1.1× ANAPTYSBIO, INC). ANAPTYSBIO, INC runs the higher net margin — 45.8% vs -14.7%, a 60.5% gap on every dollar of revenue. On growth, ANAPTYSBIO, INC posted the faster year-over-year revenue change (151.1% vs -4.8%). ANAPTYSBIO, INC produced more free cash flow last quarter ($98.0M vs $1.2M). Over the past eight quarters, ANAPTYSBIO, INC's revenue compounded faster (288.3% CAGR vs -1.0%).

AnaptysBio, Inc. is a clinical-stage biotechnology company focused on developing antibody-based immunotherapies for inflammatory diseases, immuno-oncology indications, and rare disease conditions. It primarily serves the U.S. market, advancing its innovative product candidate pipeline to address unmet medical needs via rigorous research and clinical development.

Xperi Inc. is an American multinational technology company headquartered in San Jose, California, that develops software for consumer electronics and connected cars, as well as media platforms for video service over broadband. The company is organized into four business units: Pay TV, Consumer Electronics, Connected Car, and Media Platform. Xperi's brands include DTS, HD Radio, and TiVo.

ANAB vs XPER — Head-to-Head

Bigger by revenue
XPER
XPER
1.1× larger
XPER
$116.5M
$108.2M
ANAB
Growing faster (revenue YoY)
ANAB
ANAB
+155.9% gap
ANAB
151.1%
-4.8%
XPER
Higher net margin
ANAB
ANAB
60.5% more per $
ANAB
45.8%
-14.7%
XPER
More free cash flow
ANAB
ANAB
$96.8M more FCF
ANAB
$98.0M
$1.2M
XPER
Faster 2-yr revenue CAGR
ANAB
ANAB
Annualised
ANAB
288.3%
-1.0%
XPER

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ANAB
ANAB
XPER
XPER
Revenue
$108.2M
$116.5M
Net Profit
$49.6M
$-17.1M
Gross Margin
Operating Margin
61.8%
-12.7%
Net Margin
45.8%
-14.7%
Revenue YoY
151.1%
-4.8%
Net Profit YoY
327.8%
-137.0%
EPS (diluted)
$1.64
$-0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ANAB
ANAB
XPER
XPER
Q4 25
$108.2M
$116.5M
Q3 25
$76.3M
$111.6M
Q2 25
$22.3M
$105.9M
Q1 25
$27.8M
$114.0M
Q4 24
$43.1M
$122.4M
Q3 24
$30.0M
$132.9M
Q2 24
$11.0M
$119.6M
Q1 24
$7.2M
$118.8M
Net Profit
ANAB
ANAB
XPER
XPER
Q4 25
$49.6M
$-17.1M
Q3 25
$15.1M
$-6.1M
Q2 25
$-38.6M
$-14.8M
Q1 25
$-39.3M
$-18.4M
Q4 24
$-21.8M
$46.2M
Q3 24
$-32.9M
$-16.8M
Q2 24
$-46.7M
$-30.3M
Q1 24
$-43.9M
$-13.1M
Operating Margin
ANAB
ANAB
XPER
XPER
Q4 25
61.8%
-12.7%
Q3 25
45.5%
-1.2%
Q2 25
-117.5%
-10.5%
Q1 25
-99.2%
-14.4%
Q4 24
-22.4%
-11.7%
Q3 24
-75.8%
-14.0%
Q2 24
-367.5%
-18.3%
Q1 24
-587.8%
-27.2%
Net Margin
ANAB
ANAB
XPER
XPER
Q4 25
45.8%
-14.7%
Q3 25
19.8%
-5.5%
Q2 25
-173.5%
-14.0%
Q1 25
-141.6%
-16.1%
Q4 24
-50.5%
37.8%
Q3 24
-109.4%
-12.6%
Q2 24
-425.3%
-25.3%
Q1 24
-612.0%
-11.0%
EPS (diluted)
ANAB
ANAB
XPER
XPER
Q4 25
$1.64
$-0.37
Q3 25
$0.52
$-0.13
Q2 25
$-1.34
$-0.32
Q1 25
$-1.28
$-0.41
Q4 24
$-0.63
$1.02
Q3 24
$-1.14
$-0.37
Q2 24
$-1.71
$-0.67
Q1 24
$-1.64
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ANAB
ANAB
XPER
XPER
Cash + ST InvestmentsLiquidity on hand
$238.2M
$96.8M
Total DebtLower is stronger
$27.7M
Stockholders' EquityBook value
$37.2M
$414.1M
Total Assets
$364.4M
$615.8M
Debt / EquityLower = less leverage
0.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ANAB
ANAB
XPER
XPER
Q4 25
$238.2M
$96.8M
Q3 25
$109.8M
$96.8M
Q2 25
$44.3M
$95.1M
Q1 25
$98.6M
$88.0M
Q4 24
$123.1M
$130.6M
Q3 24
$191.6M
$72.7M
Q2 24
$71.8M
$92.5M
Q1 24
$53.7M
$95.2M
Total Debt
ANAB
ANAB
XPER
XPER
Q4 25
$27.7M
Q3 25
$27.7M
Q2 25
$27.7M
Q1 25
$27.7M
Q4 24
$27.7M
Q3 24
$27.7M
Q2 24
$27.7M
Q1 24
$27.7M
Stockholders' Equity
ANAB
ANAB
XPER
XPER
Q4 25
$37.2M
$414.1M
Q3 25
$-29.4M
$421.0M
Q2 25
$-44.7M
$419.8M
Q1 25
$34.0M
$418.9M
Q4 24
$70.9M
$429.1M
Q3 24
$84.4M
$377.4M
Q2 24
$9.9M
$388.7M
Q1 24
$47.8M
$399.1M
Total Assets
ANAB
ANAB
XPER
XPER
Q4 25
$364.4M
$615.8M
Q3 25
$353.1M
$628.8M
Q2 25
$335.3M
$629.2M
Q1 25
$422.1M
$633.5M
Q4 24
$483.8M
$667.8M
Q3 24
$493.4M
$616.2M
Q2 24
$427.4M
$619.2M
Q1 24
$405.8M
$630.4M
Debt / Equity
ANAB
ANAB
XPER
XPER
Q4 25
0.07×
Q3 25
0.07×
Q2 25
0.07×
Q1 25
0.07×
Q4 24
0.06×
Q3 24
0.07×
Q2 24
0.07×
Q1 24
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ANAB
ANAB
XPER
XPER
Operating Cash FlowLast quarter
$98.0M
$4.1M
Free Cash FlowOCF − Capex
$98.0M
$1.2M
FCF MarginFCF / Revenue
90.5%
1.0%
Capex IntensityCapex / Revenue
0.0%
2.5%
Cash ConversionOCF / Net Profit
1.98×
TTM Free Cash FlowTrailing 4 quarters
$19.6M
$-5.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ANAB
ANAB
XPER
XPER
Q4 25
$98.0M
$4.1M
Q3 25
$-27.4M
$7.5M
Q2 25
$-40.2M
$10.1M
Q1 25
$-10.7M
$-22.3M
Q4 24
$-66.7M
$1.2M
Q3 24
$-10.1M
$-4.6M
Q2 24
$-21.3M
$-2.1M
Q1 24
$-37.3M
$-49.8M
Free Cash Flow
ANAB
ANAB
XPER
XPER
Q4 25
$98.0M
$1.2M
Q3 25
$-27.4M
$6.7M
Q2 25
$-40.3M
$9.5M
Q1 25
$-10.7M
$-23.3M
Q4 24
$-66.9M
$-510.0K
Q3 24
$-10.1M
$-5.6M
Q2 24
$-21.4M
$-2.6M
Q1 24
$-37.3M
$-51.6M
FCF Margin
ANAB
ANAB
XPER
XPER
Q4 25
90.5%
1.0%
Q3 25
-35.9%
6.0%
Q2 25
-180.9%
9.0%
Q1 25
-38.7%
-20.5%
Q4 24
-155.3%
-0.4%
Q3 24
-33.7%
-4.2%
Q2 24
-194.6%
-2.2%
Q1 24
-519.3%
-43.4%
Capex Intensity
ANAB
ANAB
XPER
XPER
Q4 25
0.0%
2.5%
Q3 25
0.0%
0.7%
Q2 25
0.2%
0.5%
Q1 25
0.1%
0.9%
Q4 24
0.6%
1.4%
Q3 24
0.1%
0.8%
Q2 24
0.3%
0.4%
Q1 24
0.4%
1.6%
Cash Conversion
ANAB
ANAB
XPER
XPER
Q4 25
1.98×
Q3 25
-1.81×
Q2 25
Q1 25
Q4 24
0.03×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ANAB
ANAB

Segment breakdown not available.

XPER
XPER

Pay TV$56.2M48%
Connected Car$31.3M27%
Consumer Electronics$17.2M15%
Media Platform$11.8M10%

Related Comparisons